ZIVO Bioscience (ZIVO) Competitors $13.50 0.00 (0.00%) As of 07/11/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock ZIVO vs. CGC, PRQR, NBTX, YMAB, IMAB, CRDF, INBX, MDWD, SOPH, and MNPRShould you be buying ZIVO Bioscience stock or one of its competitors? The main competitors of ZIVO Bioscience include Canopy Growth (CGC), ProQR Therapeutics (PRQR), Nanobiotix (NBTX), Y-mAbs Therapeutics (YMAB), I-Mab (IMAB), Cardiff Oncology (CRDF), Inhibrx Biosciences (INBX), MediWound (MDWD), SOPHiA GENETICS (SOPH), and Monopar Therapeutics (MNPR). These companies are all part of the "pharmaceutical products" industry. ZIVO Bioscience vs. Its Competitors Canopy Growth ProQR Therapeutics Nanobiotix Y-mAbs Therapeutics I-Mab Cardiff Oncology Inhibrx Biosciences MediWound SOPHiA GENETICS Monopar Therapeutics ZIVO Bioscience (NASDAQ:ZIVO) and Canopy Growth (NASDAQ:CGC) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, valuation, risk, earnings and media sentiment. Do insiders and institutionals hold more shares of ZIVO or CGC? 12.8% of ZIVO Bioscience shares are owned by institutional investors. Comparatively, 3.3% of Canopy Growth shares are owned by institutional investors. 48.9% of ZIVO Bioscience shares are owned by company insiders. Comparatively, 1.3% of Canopy Growth shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Does the media refer more to ZIVO or CGC? In the previous week, Canopy Growth had 11 more articles in the media than ZIVO Bioscience. MarketBeat recorded 11 mentions for Canopy Growth and 0 mentions for ZIVO Bioscience. Canopy Growth's average media sentiment score of 0.86 beat ZIVO Bioscience's score of 0.00 indicating that Canopy Growth is being referred to more favorably in the news media. Company Overall Sentiment ZIVO Bioscience Neutral Canopy Growth Positive Which has more risk & volatility, ZIVO or CGC? ZIVO Bioscience has a beta of -0.06, indicating that its share price is 106% less volatile than the S&P 500. Comparatively, Canopy Growth has a beta of 0.73, indicating that its share price is 27% less volatile than the S&P 500. Which has better earnings & valuation, ZIVO or CGC? ZIVO Bioscience has higher earnings, but lower revenue than Canopy Growth. ZIVO Bioscience is trading at a lower price-to-earnings ratio than Canopy Growth, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioZIVO Bioscience$15.85K3,251.07-$7.78M-$4.93-2.74Canopy Growth$225.65M0.92-$429.86M-$4.04-0.28 Is ZIVO or CGC more profitable? ZIVO Bioscience has a net margin of 0.00% compared to Canopy Growth's net margin of -195.76%. ZIVO Bioscience's return on equity of 0.00% beat Canopy Growth's return on equity.Company Net Margins Return on Equity Return on Assets ZIVO BioscienceN/A N/A -2,240.92% Canopy Growth -195.76%-88.54%-40.78% Do analysts rate ZIVO or CGC? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ZIVO Bioscience 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Canopy Growth 2 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 SummaryCanopy Growth beats ZIVO Bioscience on 8 of the 14 factors compared between the two stocks. Get ZIVO Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for ZIVO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ZIVO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ZIVO vs. The Competition Export to ExcelMetricZIVO BioscienceBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$51.53M$216.26M$5.56B$9.11BDividend YieldN/AN/A5.06%4.01%P/E Ratio-2.77N/A28.2620.27Price / Sales3,251.07253.11434.99100.89Price / CashN/A22.4437.1257.67Price / Book-16.676.158.045.49Net Income-$7.78M-$96.61M$3.19B$250.45M7 Day Performance12.59%12.02%3.62%4.78%1 Month Performance-3.50%11.51%5.98%9.58%1 Year Performance59.76%7.49%29.39%16.41% ZIVO Bioscience Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ZIVOZIVO BioscienceN/A$13.50flatN/A+59.8%$51.53M$15.85K-2.7710CGCCanopy Growth0.4039 of 5 stars$1.22flat$2.00+63.9%-82.6%$224.32M$225.65M-0.303,150PRQRProQR Therapeutics2.5457 of 5 stars$2.04flat$8.00+292.2%+25.4%$214.63M$20.46M-5.83180Analyst ForecastNBTXNanobiotix2.8017 of 5 stars$4.73+4.4%$8.00+69.1%-7.2%$213.34M$39.18M0.00100Positive NewsGap UpYMABY-mAbs Therapeutics4.198 of 5 stars$4.51-4.0%$15.60+245.9%-65.0%$212.84M$88.66M-7.05150IMABI-Mab2.8936 of 5 stars$2.42-5.8%$6.00+147.9%+23.8%$209.87M$3.89M0.00380Analyst ForecastGap UpCRDFCardiff Oncology1.3856 of 5 stars$3.15flat$9.88+213.5%+62.2%$209.56M$680K-3.4220Analyst ForecastINBXInhibrx Biosciences2.5625 of 5 stars$14.27-1.1%N/A+63.8%$208.89M$200K0.12166News CoverageMDWDMediWound1.8367 of 5 stars$19.37+0.6%$31.80+64.2%-5.3%$208.16M$20.22M-9.2780SOPHSOPHiA GENETICS2.7427 of 5 stars$3.10+0.3%$7.00+125.8%-25.1%$206.06M$65.17M-3.10520Positive NewsMNPRMonopar Therapeutics2.0297 of 5 stars$35.78+6.5%$56.50+57.9%+936.1%$205.47MN/A-10.2810Analyst RevisionGap Up Related Companies and Tools Related Companies CGC Alternatives PRQR Alternatives NBTX Alternatives YMAB Alternatives IMAB Alternatives CRDF Alternatives INBX Alternatives MDWD Alternatives SOPH Alternatives MNPR Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ZIVO) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ZIVO Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ZIVO Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ZIVO Stock Alerts